Cargando…

Real-life results of switching from preserved to preservative-free artificial tears containing hyaluronate in patients with dry eye disease

BACKGROUND: Dry eye disease (DED) is a chronic, multifactorial disease of the ocular surface leading to discomfort, visual disturbance, and tear film instability, with potential damage to the ocular surface. AIM: The aim of this study was to assess the clinical benefit of a switch from preserved to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nasser, Linda, Rozycka, Malgorzata, Gomez Rendon, Gabriela, Navas, Alejandro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2018
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6112802/ https://www.ncbi.nlm.nih.gov/pubmed/30197497 http://dx.doi.org/10.2147/OPTH.S160053

Ejemplares similares

Safety and Efficacy of a Preservative-Free Artificial Tear Containing Carboxymethylcellulose and Hyaluronic Acid for Dry Eye Disease: A Randomized, Controlled, Multicenter 3-Month Study
por: Aragona, Pasquale, et al.
Publicado: (2020)

Synergistic Effect of Artificial Tears Containing Epigallocatechin Gallate and Hyaluronic Acid for the Treatment of Rabbits with Dry Eye Syndrome
por: Tseng, Ching-Li, et al.
Publicado: (2016)

Corneal-Protective Effects of an Artificial Tear Containing Sodium Hyaluronate and Castor Oil on a Porcine Short-Term Dry Eye Model
por: HASEGAWA, Takashi, et al.
Publicado: (2014)

The use of preservatives in dry eye drops
por: Walsh, Karen, et al.
Publicado: (2019)

Improving Visual Comfort during Computer Gaming with Preservative-Free Hyaluronic Acid Artificial Tears Added to Ergophthalmological Measures
por: Trancoso Vaz, Fernando, et al.
Publicado: (2023)

Effect of Refresh Plus(®) preservative-free lubricant eyedrops on tear ferning patterns in dry eye and normal eye subjects
por: Alanazi, Saud A, et al.
Publicado: (2019)

Use of preservative-free hyaluronic acid (Hylabak(®)) for a range of patients with dry eye syndrome: experience in Russia
por: Brjesky, Vladimir Vsevolodovich, et al.
Publicado: (2014)

Dry eye: why artificial tears are not always the answer
por: Kim, Minji, et al.
Publicado: (2021)

Effect of preserved and preservative-free timolol eye drops on tear film stability in healthy Africans
por: Ilechie, Alex, et al.
Publicado: (2016)

Efficacy of Artificial Tears Based on an Extract of Artemia salina Containing Dinucleotides in a Rabbit Dry Eye Model
por: Carpena-Torres, Carlos, et al.
Publicado: (2021)

Corneal protective effects of novel tear substitutes containing sodium hyaluronate and dodecahydrosqualene, squalane, in a porcine dry eye model
por: HAGI, Kiyomi, et al.
Publicado: (2021)

Personalized Management of Dry Eye Disease: Beyond Artificial Tears
por: Matossian, Cynthia, et al.
Publicado: (2022)

Improved Tear Film Stability in Patients with Dry Eye After Hyaluronic Acid and Galactoxyloglucan Use
por: Molina-Solana, Pedro, et al.
Publicado: (2020)

Microbial Contamination of Preservative-Free Artificial Tears Based on Instillation Techniques
por: Lee, Jee-Hye, et al.
Publicado: (2022)

Safety and efficacy of pilocarpine, cevimeline, and diquafosol compared to artificial tears for the treatment of dry eye: protocol for a systematic review
por: Serrano-Robles, José Gerardo, et al.
Publicado: (2022)

Artificial Tears: Biological Role of Their Ingredients in the Management of Dry Eye Disease
por: Labetoulle, Marc, et al.
Publicado: (2022)

Evaluation of a preservative-free, cross-linked sodium hyaluronate-based solution, Lacri +(®), in dogs with dry eye: a pilot trial
por: Gard, Carole, et al.
Publicado: (2023)

Impact of Hyaluronic Acid-Containing Artificial Tear Products on Reepithelialization in an In Vivo Corneal Wound Model
por: Carlson, Eric, et al.
Publicado: (2018)

Novel Artificial Tears Containing Cross-Linked Hyaluronic Acid: An In Vitro Re-Epithelialization Study
por: Fallacara, Arianna, et al.
Publicado: (2017)

Effects of Sodium Hyaluronate Eye Drops With or Without Preservatives on Ocular Surface Bacterial Microbiota
por: Zhong, Yanlin, et al.
Publicado: (2022)

Effect of artificial tears on dynamic optical quality in patients with dry eye disease
por: Wei, Zhenyu, et al.
Publicado: (2022)

Tear proteomics in dry eye disease
por: Kannan, Ramaraj, et al.
Publicado: (2023)

Hyaluronic acid in the treatment of dry eye disease
por: Hynnekleiv, Leif, et al.
Publicado: (2022)

Efficacy of an artificial tear emulsion in patients with dry eye associated with meibomian gland dysfunction
por: Sindt, Christine W, et al.
Publicado: (2013)

Evaluation of a Novel Artificial Tear in the Prevention and Treatment of Dry Eye in an Animal Model
por: She, Yujing, et al.
Publicado: (2015)

The efficacy of ocular surface assessment approaches in evaluating dry eye treatment with artificial tears
por: Szczesna-Iskander, Dorota H., et al.
Publicado: (2022)

Artificial intelligence to estimate the tear film breakup time and diagnose dry eye disease
por: Shimizu, Eisuke, et al.
Publicado: (2023)

Evaluation of a new artificial tear formulation for the management of tear film stability and visual function in patients with dry eye
por: Torkildsen, Gail, et al.
Publicado: (2017)

Tear Film Stabilization and Symptom Improvement in Dry Eye Disease: The Role of Hyaluronic Acid and Trehalose Eyedrops versus Carmellose Sodium
por: Sánchez-González, José-María, et al.
Publicado: (2023)

Tear osmolarity and dry eye symptoms in diabetics
por: Fuerst, Nicole, et al.
Publicado: (2014)

Tear Luminex Analysis in Dry Eye Patients
por: Zhao, Hailan, et al.
Publicado: (2018)

Drug-eluting contact lens containing cyclosporine-loaded cholesterol-hyaluronate micelles for dry eye syndrome
por: Mun, Jonghwan, et al.
Publicado: (2019)

Freeze-drying for the preservation of immunoengineering products
por: Kommineni, Nagavendra, et al.
Publicado: (2022)

The Lubricating Effect of Eye Drops Containing Hyaluronic Acid and Mallow Extract in Patients with Dry Eye Disease—A Pilot Study
por: Basile, Andrea Attilio, et al.
Publicado: (2023)

Observations on the Management and Preservation of the Eyes
por: Lang,
Publicado: (1805)

The Giant Magnet as an Eye Preserver
por: Cox, Ross P.
Publicado: (1906)

Switching patients from preserved prostaglandin-analog monotherapy to preservative-free tafluprost
por: Hommer, Anton, et al.
Publicado: (2011)

The Effect of Artificial Tear Preparations with Three Different Ingredients on Contrast Sensitivity in Patients with Dry Eye Syndrome
por: Akkaya, Sezen
Publicado: (2018)

Effects of a warm compress containing menthol on the tear film in healthy subjects and dry eye patients
por: Arita, Reiko, et al.
Publicado: (2017)

Tear Metabolomics in Dry Eye Disease: A Review
por: Yazdani, Mazyar, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_sehs1ge3l74n85tkp867b71hlv